Literature DB >> 21642380

Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer.

Ching-Chi Chiu1, Chien-Yu Lin, Li-Yu Lee, Yin-Ju Chen, Ya-Ching Lu, Hung-Ming Wang, Chun-Ta Liao, Joseph Tung-Chieh Chang, Ann-Joy Cheng.   

Abstract

PURPOSE: The goal of this study was to establish a common set of molecules that regulate cell invasion in head and neck cancer (HNC). EXPERIMENTAL
DESIGN: Five invasive sublines derived from HNC cell lines were established using the Matrigel selection method. Proteomic technology, MetaCore algorithm, and reverse transcriptase-PCR methods were used to search for molecules that contribute to the invasion phenotype. Cellular functional analyses and clinical association studies were applied to examine the significance of the molecules.
RESULTS: Fifty-two proteins were identified in more than two of the four independent proteomic experiments, including 10 (19%) molecular chaperones. Seven chaperones were confirmed to be differentially expressed in five sublines, Hsp90α, Hsp90β, Hsp90-B1/Gp96, Hsp70-A5/Grp78, and HYOU1, that upregulate, whereas Hsp60 and glucosidase-α neutral AB (GANAB) downregulate. Four molecules were further investigated. In all cell lines, knockdown of Hsp60 or GANAB and silencing of Gp96 or Grp78 considerably enhanced or reduced cell migration and invasion, respectively. Clinical association studies consistently revealed that low levels of Hsp60 or GANAB and high levels of Gp96 or Grp78 are significantly associated with advanced cancer (P < 0.001 to P = 0.047, respectively, for the four molecules) and poor survival (P < 0.001 to P = 0.025, respectively, for the four molecules).
CONCLUSION: Our study defined molecular chaperones as a common set of proteins that regulate the invasion phenotype of HNC. Loss of the tumor suppression function of Hsp60 or GANAB and acquisition of the oncogenic function of Gp96 or Grp78 contribute to aggressive cancers. These molecules may serve as prognostic markers and targets for cancer drug development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642380     DOI: 10.1158/1078-0432.CCR-10-2107

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  26 in total

1.  A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion.

Authors:  Katarina Valoskova; Julia Biebl; Marko Roblek; Shamsi Emtenani; Attila Gyoergy; Michaela Misova; Aparna Ratheesh; Patricia Reis-Rodrigues; Kateryna Shkarina; Ida Signe Bohse Larsen; Sergey Y Vakhrushev; Henrik Clausen; Daria E Siekhaus
Journal:  Elife       Date:  2019-03-26       Impact factor: 8.140

2.  Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.

Authors:  Louise Giffin; Feng Yan; M Ben Major; Blossom Damania
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.

Authors:  Yung-Chin Hsiao; Lang-Ming Chi; Kun-Yi Chien; Wei-Fan Chiang; Szu-Fan Chen; Yao-Ning Chuang; Shih-Yu Lin; Chia-Chun Wu; Ya-Ting Chang; Lichieh Julie Chu; Yi-Ting Chen; Shu-Li Chia; Chih-Yen Chien; Kai-Ping Chang; Yu-Sun Chang; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2017-08-18       Impact factor: 5.911

4.  BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.

Authors:  David M Gau; Jamie L Lesnock; Brian L Hood; Rohit Bhargava; Mai Sun; Kathleen Darcy; Soumya Luthra; Uma Chandran; Thomas P Conrads; Robert P Edwards; Joseph L Kelley; Thomas C Krivak; Partha Roy
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Expressions of GRP78 and Bax associate with differentiation, metastasis, and apoptosis in non-small cell lung cancer.

Authors:  Qing Sun; Jun Hua; Qi Wang; Wei Xu; Jiaxing Zhang; Jun Zhang; Jiuhong Kang; Maoquan Li
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

Review 6.  Targeting the unfolded protein response in head and neck and oral cavity cancers.

Authors:  Daniel W Cole; Peter F Svider; Kerolos G Shenouda; Paul B Lee; Nicholas G Yoo; Thomas M McLeod; Sean A Mutchnick; George H Yoo; Randal J Kaufman; Michael U Callaghan; Andrew M Fribley
Journal:  Exp Cell Res       Date:  2019-05-07       Impact factor: 3.905

Review 7.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

8.  The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival.

Authors:  Koji Matsuo; Michael J Gray; Dong Yun Yang; Sucheta A Srivastava; Prem B Tripathi; Laura A Sonoda; Eun-Jeong Yoo; Louis Dubeau; Amy S Lee; Yvonne G Lin
Journal:  Gynecol Oncol       Date:  2012-11-28       Impact factor: 5.482

Review 9.  Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94.

Authors:  Ephraim A Ansa-Addo; Jessica Thaxton; Feng Hong; Bill X Wu; Yongliang Zhang; Caroline W Fugle; Alessandra Metelli; Brian Riesenberg; Katelyn Williams; Daniel T Gewirth; Gabriela Chiosis; Bei Liu; Zihai Li
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

10.  Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer.

Authors:  Guo-Rung You; Joseph T Chang; Yan-Liang Li; Yin-Ju Chen; Yu-Chen Huang; Kang-Hsing Fan; Yen-Chao Chen; Chung-Jan Kang; Ann-Joy Cheng
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.